Fabrication and evaluation of fast disintegrating pellets of cilostazol

References

• Kumari MH, Samatha K, Balaji A, et al. Recent novel advandcements in pellet formulation: a review. Int J Pharm Sci Res. 2013;4(10):3803–3822.
   Google Scholar
• Kumar S, Das B, Raju R. Formulation and evaluation of multiunit pellet system of venlafaxine hydrochloride. J Pharm Biomed Sci. 2012;18(18):1–12.
   Google Scholar
• Lavanya K. Pelletization technology: a quick review. IJPSR. 2011;2(6):1337–1355.
   Google Scholar
• Manivannan R, Ganesan Parthiban K, Sandeep G, et al. Multiparticlate drug delivery systems: pellet & pelletization technique. Drug Invent Today. 2010;2(5):233–237.
   Google Scholar
• Charoenthai N, Kleinebudde P, Puttipipatkhachorn S. Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose. AAPS PharmSciTech. 2007;8(3):E99–E109.
   PubMed Web of Science ®Google Scholar
• Dukić-Ott A, Thommes M, Remon JP, et al. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review. Eur J Pharm Biopharm. 2009;71(1):38–46.
   PubMed Web of Science ®Google Scholar
• Otero-Espinar FJ, Luzardo-Alvarez A, Blanco-Méndez J. Non-MCC materials as extrusion-spheronization aids in pellets production. J Drug Deliv Sci Technol. 2010;20(4):303–318.
   Web of Science ®Google Scholar
• Dukić A, Mens R, Adriaensens P, et al. Development of starch-based pellets via extrusion/spheronisation. Eur J Pharm Biopharm. 2007;66(1):83–94.
   PubMed Web of Science ®Google Scholar
• Goyanes A, Martínez-Pacheco R. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization. Drug Dev Ind Pharm. 2015;41(3):362–368.
   PubMed Web of Science ®Google Scholar
• Dukić-Ott A, Remon JP, Foreman P, et al. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation. Eur J Pharm Biopharm. 2007;67(3):715–724.
   PubMed Web of Science ®Google Scholar
• Nagpal M, Goyal A, Kumar S, et al. Starch-silicon dioxide coprecipitate as superdisintegrant: formulation and evaluation of fast disintegrating tablets. Int J Drug Deliv. 2012;4:164–174.
   Google Scholar
• Sinha V, Agrawal M, Kumria R. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization. Curr Drug Deliv. 2005;2(1):1–8.
   PubMedGoogle Scholar
• Blanqué D, Sternagel H, Podczeck F, et al. Some factors influencing the formation and in vitro drug release from matrix pellets prepared by extrusion/spheronization. Int J Pharm. 1995;119(2):203–211.
   Web of Science ®Google Scholar
• Tapia C, Buckton G, Newton JM. Factors influencing the mechanism of release from sustained release matrix pellets, produced by extrusion/spheronisation. Int J Pharm. 1993;92(1–3):211–218.
   Google Scholar
• Partheniadis I, Gkogkou P, Kantiranis N, et al. Modulation of the release of a non-interacting low solubility drug from chitosan pellets using different pellet size, composition and numerical optimization. Pharmaceutics. 2019;11(4):175.
   Web of Science ®Google Scholar
• Santos H, Veiga F, Pina M, et al. 2002. Physical properties of chitosan pellets produced by extrusion – spheronisation: influence of formulation variables. Int J Pharm. 2002;246(1–2):153–169.
   PubMedGoogle Scholar
• Patel SG, Rajput SJ. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes. AAPS PharmSciTech. 2009;10(2):660–669.
   PubMed Web of Science ®Google Scholar
• Miao X, Sun C, Jiang T, et al. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol. J Pharm Pharm Sci. 2011;14(2):196–214.
   PubMed Web of Science ®Google Scholar
• Li J, Jiang Q, Deng P, et al. The formation of a host-guest inclusion complex system between β-cyclodextrin and baicalin and its dissolution characteristics. J Pharm Pharmacol. 2017;69(6):663–674.
   PubMed Web of Science ®Google Scholar
• Onn G, Loh K, Tze Y, et al. Enhancement of norfloxacin solubility via inclusion complexation with β-cyclodextrin and its derivative hydroxypropyl- β-cyclodextrin. Asian J Pharm Sci. 2016;11(4):536–546.
   Web of Science ®Google Scholar
• Patil JS, Kadam DV, Marapur SC, et al. Inclusion complex system; a novel technique to improve the solubility and bioavailability of poorly soluble drugs: a review. Int J Pharm Sci Rev Res. 2010a;2(2):29–34.
   Google Scholar
• Kulkarni AD, Belgamwar VS. Inclusion complex of chrysin with sulfobutyl ether-β-cyclodextrin (Captisol®): preparation, characterization, molecular modelling and in vitro anticancer activity. J Mol Struct. 2017;1128(January 2017):563–571.
   Google Scholar
• Teja B, Pradesh A, Nagar P, et al. Studies on solubility and dissolution enhancement of itraconazole by complexation with sulfo-butyl7 ether β cyclodextrin. Asian J Biomed Pharm Sci. 2014;4(38):6–16.
   Google Scholar
• Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instrum. 1965;4:117.
   Google Scholar
• Desai C, Prabhakar B. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes. Drug Dev Ind Pharm. 2015;41(10):1589–1607.
   PubMed Web of Science ®Google Scholar
• Patil JS, Pandya NR, Marapur SC, et al. Influence of method of preparation on physico-chemical properties and in-vitro drug release profile of nimodipine-cyclodextrin inclusion complexes: a comparative study. Int J Pharm Pharm Sci. 2010;2(1):71–81.
   Google Scholar
• Moyano JR, Arias-Blanco MJ, Ginésa JM, et al. Solid-state characterization and dissolution characteristics of gliclazide-β-cyclodextrin inclusion complexes. Int J Pharm. 1997;148(2):211–217.
   Google Scholar
• Creteanu A, Pamfil D, Vasile C, et al. Study on the role of the inclusion complexes with 2-hydroxypropyl- β -cyclodextrin for oral administration of amiodarone. Int J Polymer Sci. 2019;2019:1–23.
   Web of Science ®Google Scholar
• luorence T, Malyadri T, Thejomoorthy K, et al. Enhancement of dissolution of cilostazole by complexation method using cyclodextrins. World J Curr Med Pharm Res. 2011;9(August):5–13.
   Google Scholar
• Jain SP, Singh PP, Amin PD. Alternative extrusion-spheronization aids. Drug Dev Ind Pharm. 2010;36(11):1364–1376.
   PubMed Web of Science ®Google Scholar
• Jain SP, Singh PP, Javeer S, et al. Use of Placket – Burman statistical design to study effect of formulation variables on the release of drug from hot melt sustained release extrudates. AAPS PharmSciTech. 2010;11(2):936–944.
   PubMed Web of Science ®Google Scholar
• Gurram RK, Gandra S, Shastri NR. Design and optimization of disintegrating pellets of MCC by non-aqueous extrusion process using statistical tools. Eur J Pharm Sci. 2016;84:146–156.
   PubMed Web of Science ®Google Scholar
• Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic ‘design of experiments.’ Part I: fundamental aspects. Crit Rev Ther Drug Carrier Syst. 2005;22(1):27–105.
   PubMed Web of Science ®Google Scholar
• Patel H, Patel H, Gohel M, et al. Dissolution rate improvement of telmisartan through modified MCC pellets using 32 full factorial design. Saudi Pharm J. 2016;24(5):579–587.
   PubMed Web of Science ®Google Scholar
• Singh B, Ahuja N. Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: optimization of bioadhesion, dissolution, and diffusion parameters. Drug Dev Ind Pharm. 2002;28(4):431–442.
   PubMed Web of Science ®Google Scholar
• Pal S, Gauri SK. A desirability functions-based approach for simultaneous optimization of quantitative and ordinal response variables in industrial processes. Int J Eng Sci Tech. 2018;10(1):76.
   Google Scholar
• Lewis GA, Mathieu R, Phan-Tan-Luu. Pharmaceuticalexperimental design. New York (NY): Marcel Dekker, 1999.
   Google Scholar
• Jadhav N, Gade M, Salunkhe N, et al. Extrusion-spheronization of talc using microcrystalline cellulose as a pellet aid: part I. J Pharm Innov. 2014;9(4):321–330.
   Web of Science ®Google Scholar
• Noor A, Aravind P, Nagar P, et al. Formulation development and in vitro evaluation of immediate release fenofibrate pellets. Drug Des Devel Ther. 2014;02(03):1–6.
   Google Scholar
• Kleinebudde P. Application of low substituted hydroxypropylcellulose (L-HPC) in the production of pellets using extrusion/spheronization. Int J Pharm. 1993;96(1–3):119–128.
   Google Scholar
• Akhgari A, Abbaspour MR, Pirmoradi S. Preparation and evaluation of pellets using acacia and tragacanth by extrusion-spheronization. DARU. 2011;19(6):417–423.
   PubMed Web of Science ®Google Scholar
• Gidey G. International Journal of Pharmaceutical Sciences and Research 1918. J Pharm Sci. 2013;4(5):1918–1929.
   Google Scholar
• Al-Hashemi HMB, Baghabra Al-Amoudi OS. A review on the angle of repose of granular materials. Powder Technol. 2018;330:397–417.
   Web of Science ®Google Scholar
• Kaur V, Goyal AK, Ghosh G, et al. Development and characterization of pellets for targeted delivery of 5-fluorouracil and phytic acid for treatment of colon cancer in Wistar rat. Heliyon. 2020;6(1):e03125.
   PubMed Web of Science ®Google Scholar
• Gawali VU, Patil PB, Chede SM, et al. Studies on cilostazol and β-cyclodextrin inclusion complexes. Int J Pharmtech Res. 2009;1(4):1073–1078.
   Google Scholar
• Singh G, Pai RS, Kusum Devi V. Optimization of pellets containing solid dispersion prepared by extrusion/spheronization using central composite design and desirability function. J Young Pharm. 2012;4(3):146–156.
   PubMedGoogle Scholar
• Venuti V, Stancanelli R, Acri G, et al. Host-guest’ interactions in Captisol®/Coumestrol inclusion complex: UV–Vis, FTIR-ATR and Raman studies. J Mol Struct. 2017;1146:512–521.
   Web of Science ®Google Scholar
• Verma S, Rudraraju VS. A systematic approach to design and prepare solid dispersions of poorly water-soluble drug. AAPS PharmSciTech. 2014;15(3):641–657.
   PubMed Web of Science ®Google Scholar
• Yu LX. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res. 2008;25(4):781–791.
   PubMed Web of Science ®Google Scholar
• Kleinebudde P. Shrinking and swelling properties of pellets containing microcrystalline cellulose and low substituted hydroxypropylcellulose: II. Swelling properties. J Pharm. 1994;109(1):221–227.
   Google Scholar
• Kleinebudde P. Development of disintegrating pellets obtained from extrusion spheronization. Pharm Sci. 1995;1:415–418.
   Google Scholar
• Al-Hashimi N, Begg N, Alany RG, et al. Oral modified release multiple-unit particulate systems: compressed pellets, microparticles and nanoparticles. Pharmaceutics. 2018;10(4):176.
   Web of Science ®Google Scholar
• Steckel H, Mindermann-Nogly F. Production of chitosan pellets by extrusion/spheronization. Eur J Pharm Biopharm. 2004;57(1):107–114.
   PubMed Web of Science ®Google Scholar
• Garekani HA, Nokhodchi A, Rayeni MA, et al. Preparation and characterization and release properties of Eudragit RS based ibuprofen pellets prepared by extrusion spheronization: effect of binder type and concentration. Drug Dev Ind Pharm. 2013;39(8):1238–1246.
   PubMed Web of Science ®Google Scholar
• Gandhi R, Ashokraj Y, Kaul CL, et al. Using extrusion – spheronization to develop controlled-release formulations of azithromycin. Pharm Technol. 2005;29(2):68–86.
   Google Scholar
• Mallipeddi R, Saripella KK, Neau SH. Use of coarse ethylcellulose and PEO in beads produced by extrusion-spheronization. Int J Pharm. 2010;385(1–2):53–65.
   PubMed Web of Science ®Google Scholar
• Zimm KR, Schwartz JB, Robert E, et al. Drug release from a multiparticulate pellet system. Pharm Dev Technol. 1996;1(1):37–42.
   PubMedGoogle Scholar
• Verheyen P, Steffens KJ, Kleinebudde P. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties. Drug Dev Ind Pharm. 2009;35(11):1325–1332.
   PubMed Web of Science ®Google Scholar
• Kharb V, Saharan VA, Dev K, et al. Formulation, evaluation and 3(2) full factorial design-based optimization of ondansetron hydrochloride incorporated taste masked microspheres. Pharm Dev Technol. 2014;19(7):839–852.
   PubMed Web of Science ®Google Scholar
• Paarakh MP, Jose PANI, Setty CM, et al. 2018. Release kinetics – concepts and applications. IJPRT. 2018;8(1):12–20.
   Google Scholar
• Nair R, Gonen S, Hoag SW. Influence of polyethylene glycol and povidone on the polymorphic transformation and solubility of carbamazepine. Int J Pharm. 2002;240(1–2):11–22.
   PubMed Web of Science ®Google Scholar
• Hancock BC, Shamblin SL, Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm Res. 1995;12(6):799–806.
   PubMed Web of Science ®Google Scholar
• Chmitt ESX, Avis CWD, Ong STL. Moisture-dependent crystallization of amorphous lamotrigine mesylate. J Pharm Sci. 1996;85(11):1215–1219.
   PubMed Web of Science ®Google Scholar
• Shalaev EY, Zografi G. How does residual water affect the solid-state degradation of drugs in the amorphous state? J Pharm Sci. 1996;85(11):1137–1141.
   PubMed Web of Science ®Google Scholar